Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Callery

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Wellcome Open Research|March 21, 2022
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness projectArjun Chandna, Rusheng Chew, Nan Shwe Nwe Htun, et al.
Eclinicalmedicine|February 3, 2025
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)Podjanee Jittamala, Simon Boyd, William H K Schilling, et al.
The Lancet. Infectious Diseases|February 14, 2026
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trialTamiru Shibiru Degaga, Ayodhia Pitaloka Pasaribu, Rupam Tripura, et al.
Lancet (London, England)|March 15, 2020
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trialRob W van der Pluijm, Rupam Tripura, Richard M Hoglund, et al.
Plos Medicine|September 12, 2024
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trialWilliam H K Schilling, Mavuto Mukaka, James J Callery, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Wellcome Open Research|March 21, 2022
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness projectArjun Chandna, Rusheng Chew, Nan Shwe Nwe Htun, et al.
Eclinicalmedicine|February 3, 2025
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)Podjanee Jittamala, Simon Boyd, William H K Schilling, et al.
The Lancet. Infectious Diseases|February 14, 2026
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trialTamiru Shibiru Degaga, Ayodhia Pitaloka Pasaribu, Rupam Tripura, et al.
Lancet (London, England)|March 15, 2020
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trialRob W van der Pluijm, Rupam Tripura, Richard M Hoglund, et al.
Plos Medicine|September 12, 2024
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trialWilliam H K Schilling, Mavuto Mukaka, James J Callery, et al.
Pageof 5